4//SEC Filing
McIntosh David M 4
Accession 0001140361-12-030694
CIK 0001228627other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:19 PM ET
Size
16.5 KB
Accession
0001140361-12-030694
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock Options (right-to-buy)
2012-06-18+20,000→ 20,000 totalExercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Options (right-to-buy)
Exercise: $1.17From: 2011-06-14Exp: 2020-06-14→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying) - 2,800(indirect: By son)
Common Stock
- 125,000
Stock Options (right-to-buy)
Exercise: $0.80From: 2007-04-20Exp: 2014-04-20→ Common Stock (125,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying) - 2,800(indirect: By daughter)
Common Stock
- 20,000
Stock Options (right-to-buy)
Exercise: $1.25From: 2012-06-06Exp: 2021-06-06→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.28From: 2010-06-01Exp: 2019-06-19→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $3.24From: 2009-06-30Exp: 2018-06-30→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $3.00From: 2006-09-12Exp: 2015-09-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest and become exercisable in full on June 18, 2013
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001317248
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:19 PM ET
- Size
- 16.5 KB